loader
Please Wait
Applying Filters...

Looking for Xarelto? Find Controlled & Modified Release used in Xarelto to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 1,706Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Gangwal Healthcare

02 5BASF

03 2Ideal Cures Pvt Ltd

04 14Kerry

05 1Kima Chemical

06 1Lonza Capsugel

07 1Sigachi Industries

08 2The Dow Chemical Company

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Brand : GELLETS-P®

Applications : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Grade : Oral

arrow

03

arrow
2024 ACI Convention
Not Confirmed

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : ESPHERES EM

Applications : These spheres can be used as an inert base for modified release formulations promoting consistency and uniformity of release profile thus ensuring a uniform therapeutic response.

Pharmacopoeia Ref : Particle Sizes - #20 – #30, #30 – #40 and #40 – #60

Technical Specs : Not Available

Grade : Oral

arrow
blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : METHOCEL™

Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

Pharmacopoeia Ref : Not Available

Technical Specs : Not Available

Grade : Not Available

arrow
blank

15

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : VCAPS® ENTERIC

Applications : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

Pharmacopoeia Ref : Complies with relevant European, Japanese and US Pharmacopeia monographs

Technical Specs : Water content – less than 6%; Size #0

Grade : Oral

arrow
blank

21

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : KOLLICOAT SR 30 D

Applications : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specs : Not Available

Grade : Not Available

arrow
blank